Cite
APA Citation
Wang, M., Belada, D., Cheah, C., Chu, M., Dreyling, M., Flinn, I., Fogliatto, L., Goy, A., Inwards, D., Jurczak, W., Mayer, J., Re, F., Robak, T., Spurgeon, S., Yoon, S., Zinzani, P., Yin, M., Chen, T., Kahl, B., & , (n.d.). a PHASE 3 STUDY OF ACALABRUTINIB PLUS BENDAMUSTINE AND RITUXIMAB IN ELDERLY (AGED ≥65 Years) TREATMENT‐NAIVE PATIENTS WITH MANTLE CELL LYMPHOMA. Hematological oncology, 37, 554–555. http://access.bl.uk/ark:/81055/vdc_100086192665.0x000043